Local and systemic inflammation that characterizes COVID-19 activates and damages the endothelium, resulting in an elevation of von Willebrand factor (vWF) in the blood, making the vasculature more susceptible to thrombotic events12–15. This evidence concerns the gene VWF and COVID-19.